GSK plc GSK Cash Flow Statement (2009-2026)

NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT
Reported Financials

Gsk Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Gsk cash flow statement data for the quarter ended Sep 2026. This cash flow statement covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
9,353.85M1,981.89M1,055.31M12,753.07M15,445.12M1,982.50M435.47M2,096.36M493.98M1,371.27M2,128.10M81.86M643.03M2,231.83M2,838.85M3,735.03M-2,851.88M2,479.30M207.96M2,911.39M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
582.34M560.89M8.21M777.93M1,462.08M696.42M1,085.84M1,036.57M1,407.32M624.21M
Share-based CompensationStock Comp.
Deferred Taxes
Cash from Discontinued OperationsCash from Discont. Ops
1,066.28M450.86M4.69M64.42M-4,433.39M1,215.24M-2,764.66M1,442.13M-2,955.63M1,538.27M
Gains from Equity InvestmentsGains Equity
6,869.46M479.04M1,982.50M2,183.63M1,943.09M6,588.03M1,371.27M1,645.94M84.45M3,787.61M2,231.83M2,195.84M2,893.03M8,365.42M2,479.30M741.95M
Gains from Investment SecuritiesGains Investment
-41.79M-331.94M-132.80M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
-403.06M265.68M-1,128.36M211.50M-369.15M-13.93M-567.21M169.98M-311.77M-16.89M178.41M136.03M-187.55M195.49M
Non-cash ItemsNon-Cash Items
Change in Working Capital
947.65M-642.74M860.93M-1,021.03M1,782.29M-394.51M1,917.55M-992.49M1,026.89M-1,458.73M
Change in ReceivablesChange Receivables
-1,051.45M-185.32M-985.47M
Change in InventoryChange Inventory
-315.52M-526.25M
Change in Account PayablesChange Payables
-18.62M
Change in Other Operating AssetsOther Assets Change
-514.94M-537.20M
Change in Other Operating LiabilitiesOther Liabilities Change
409.26M-1,586.24M961.89M-375.48M-178.41M-770.81M-375.11M68.76M
Other Working Capital ChangesOther WC Changes
514.94M409.26M537.20M-1,586.24M961.89M-375.48M-178.41M-770.81M-375.11M68.76M
Other Operating Activities (as filed)
-202.20M-77.83M-242.80M-588.31M-36.79M18.93M-113.04M-182.26M-45.34M-192.87M9.44M
Cash from OperationsCash from Ops.
5,435.18M2,960.09M3,131.72M348.85M1,635.53M2,801.91M2,920.43M1,428.35M1,404.85M2,798.69M1,641.60M1,638.61M-3,352.02M1,820.04M
Investing Activities
Capital ExpendituresCapex
2,057.06M-258.97M2,167.57M-283.21M-370.40M-378.74M2,658.55M-314.59M-381.19M-396.29M2,893.01M-261.98M413.68M-297.95M
Sales of Property, Plant and EquipmentPP&E (Sale)
18.87M8.05M156.00M8.51M3.75M13.93M8.69M1.27M2.52M1.30M78.29M1.26M-6.65M36.40M
Change in Property, Plant and EquipmentChange in PP&E
-2,038.19M267.03M-2,011.57M291.72M374.16M392.67M-2,649.86M315.86M383.72M397.59M-2,814.72M263.24M-420.33M334.35M
Change in IntangiblesChange Intangibless
4,360.81M-505.87M2,248.50M-359.79M-299.08M-250.80M2,188.15M-399.58M-176.71M-697.72M3,305.02M-302.28M755.53M-299.30M
Acquisitions
7,199.43M3,619.20M-912.06M1,993.28M-1,007.60M1,137.29M-1,892.84M
Divestments
10.78M1.34M-28.15M-7.29M-8.69M-3.81M-6.42M-1.26M-1.33M330.30M
Net of Acquisitions & DivestmentsNet Acquisitions
10.78M1.34M-7,227.58M-7.29M-3,627.89M908.26M-1,999.70M1,006.34M-1,138.62M2,223.15M
Purchase of InvestmentsInvestments Purchased
219.73M170.07M
Sale and Maturity of InvestmentsInvestments Sold
320.83M144.27M12.16M1,239.91M1,338.29M2.57M-159.62M4.04M
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing Activities (as filed)Other investing (as filed)
-24.26M6.71M-4,282.36M4.86M-3.75M-3.80M-89.36M34.25M-5.05M-5.20M-26.95M95.72M-47.89M83.59M
Cash from Investing ActivitiesCash from Investing
-486.63M-4,821.22M-633.38M-495.93M435.47M2,096.36M332.63M-189.01M414.01M1,717.67M-1,436.24M-1,440.87M2,036.48M-1,976.43M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.35M12,351.60M1,212.81M-175.03M-276.78M-1,379.76M2,541.67M8.09M
Long-Term Debt RepaymentsLT Debt Repayment
-334.12M6,867.50M670.96M1,074.84M-409.73M3,082.97M-200.26M-9.31M-26.96M
Net Long-Term Debt Issued (Repaid)Net LT Debt
1.35M12,685.71M-5,654.69M-845.99M-1,351.61M409.73M-4,462.74M2,741.93M9.31M35.05M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
3,884.97M11,839.54M539.90M
Net Short-Term Debt Issued (Repaid)Net ST Debt
2,689.28M334.12M-11,839.54M413.30M-409.73M1,040.92M-1,443.23M1,612.42M
Net Debt Issuances and RepaymentsNet Debt Issuance
1,269.83M653.47M-17,494.23M-845.99M2,677.16M100.21M2,496.41M-1,073.09M-1,806.37M-1,621.86M
Change in Capital Stock
Common Stock IssuedStock Issued
1.35M22.81M9.72M1.24M22.83M15.11M10.79M
Shares Repurchased
-311.10M1,263.34M-2,462.59M421.66M-439.51M
Net Shares Issued and RepurchasedNet Shares Issued
1.35M22.81M9.72M1.24M22.83M326.21M-1,263.34M2,462.59M-421.66M450.29M
Net Equity Issued and RepurchasedNet Equity Issued
1.35M22.81M9.72M1.24M22.83M326.21M-1,263.34M2,462.59M-421.66M450.29M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total)
9,499.43M-1,277.43M7,365.99M-674.61M4,872.76M-720.52M5,488.25M-770.81M864.61M-866.88M
Other financing activities (as filed)
289.82M12,446.87M213.47M-57.13M-171.44M-72.20M244.51M-72.31M1.26M10.39M290.07M-71.79M74.49M-71.45M
Cash from Financing ActivitiesCash from Financing
-4,164.00M-1,748.41M-1,569.38M-386.53M-4,458.22M-1,344.63M-1,080.71M1,080.65M1,749.17M366.70M
Additional items
Exchange Rate EffectFX Effect
423.28M16.10M53.95M-37.68M687.60M-24.10M150.17M-13.85M-78.48M2.70M
Change in Cash
-1,906.09M9,288.19M-8,910.74M-818.04M-580.86M-318.40M472.33M1,081.91M-235.44M-71.45M
Beginning Cash Balance
4,286.08M4,381.58M
Ending Cash Balance
5,155.03M14,409.41M4,027.70M4,129.29M3,579.92M3,877.46M3,639.37M3,522.73M4,271.95M4,270.46M5,775.65M4,428.92M4,318.93M4,534.08M3,882.49M
Free Cash FlowFCF
3,378.11M3,219.06M964.15M632.06M2,005.94M3,180.65M261.88M1,742.94M1,786.04M3,194.98M-1,251.41M1,900.59M-3,765.70M2,117.99M
Net Cash FlowNCF
784.54M-3,609.54M928.96M-533.61M2,071.01M4,898.27M-1,205.16M-105.29M1,818.86M4,516.37M-875.35M1,278.39M433.63M210.32M
Interest Paid
1,679.62M-110.03M1,585.80M-145.86M1,546.48M-90.06M1,305.32M-86.91M78.48M-114.60M
Income Taxes PaidTaxes Paid
103.80M-195.91M2,838.49M-284.43M2,694.54M-213.11M3,025.21M-196.48M396.39M-281.77M

Gsk Cash Flow Statement API

Pull Gsk's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GSK&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY